Mixed signals for DaVita
The healthcare company's strong earnings report was eclipsed by news of a standstill agreement with Berkshire Hathaway.
The solid beat on the first quarter earnings of DaVita HealthCare Partners (DVA) Tuesday night was overshadowed Wednesday morning by reports of a standstill agreement with Warren Buffett’s Berkshire Hathaway (BRK.A), that traders see as raising the odds of an acquisition.
DaVita, a member of my Jubak’s Picks portfolio, closed up 10.05% Wednesday on the combined news. I had calculated a $149 a share target price for DaVita when I added it to the portfolio on April 5. As of Wednesday, I’m leaving the target price at that level.
First, earnings. The company reported earnings of $1.84 a share (excluding one-time items) versus Wall Street expectations for $1.80 a share. Revenue climbed to $2.83 billion against the $2.79 billion analyst consensus. The company raised its guidance for 2013 operating income to $1.8 billion to $1.90 billion from prior guidance of $1.75 billion to $1.9 billion.
Second, the standstill. DaVita said Berkshire Hathaway, which already owns 14% of DaVita’s shares, had approached the company about increasing its holdings. Berkshire has agreed that, if its position exceeds 15%, it would not propose an acquisition without consent from DaVita. That would prevent an unsolicited, hostile takeover attempt by Berkshire Hathaway. But since Berkshire’s deals are typically friendly, the agreement strikes traders not as preventing an acquisition but as laying out a framework for a future deal.
Buttressing that logic are the names on the standstill agreement. On DaVita’s side, the paper was signed by president Javier Rodriguez. For Berkshire, the signatory was Ted Weschler, a former hedge fund manager recently hired by Berkshire to help oversee investments. DaVita was among the biggest holdings in Weschler’s hedge fund before he joined Berkshire.
Full disclosure: I don’t own shares of any of the companies mentioned in this post in my personal portfolio. When in 2010 I started the mutual fund I manage, Jubak Global Equity Fund, I liquidated all my individual stock holdings and put the money into the fund. The fund did not own shares in DaVita HealthCare Partners as of the end of March. For a full list of the stocks in the fund as of the end of March see the fund’s portfolio.
MSN Money on Twitter and Facebook
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
With the universe of this category in its seasonal sweet spot, these picks have tailwinds propelling them into the new year.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.